Apimeds Pharmaceuticals U... (APUS)
NYSE: APUS
· Real-Time Price · USD
1.97
0.18 (10.06%)
At close: Aug 20, 2025, 3:59 PM
Apimeds Pharmaceuticals US Inc Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Dec 31, 2022 |
Cash & Equivalents | 250.34K | 3.46K | 26.57K | 63.33K | 147.38K | 410.48K | 751.05K | 6.17K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.56K | 9.6K | 10.34K | 10.34K | 10.34K | 11.6K | n/a | n/a |
Total Current Assets | 259.9K | 13.06K | 36.91K | 73.66K | 157.72K | 422.08K | 922.73K | 6.17K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 259.9K | 13.06K | 36.91K | 73.66K | 157.72K | 422.08K | 922.73K | 6.17K |
Account Payables | n/a | n/a | n/a | n/a | n/a | n/a | 62.07K | 36.88K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 623.62K | 250K | 250K | 100K | n/a | n/a | 260K | 260K |
Other Current Liabilities | 287.05K | 180.55K | 77K | 26K | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.77M | 1.02M | 761.4K | 488.17K | 136.48K | 123.31K | 377.07K | 319.78K |
Long-Term Debt | 250K | 346.84K | 321.99K | 299.46K | 285.84K | 266.89K | 400K | 400K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 250K | 346.84K | 321.99K | 299.46K | 285.84K | 266.89K | 400K | 400K |
Total Liabilities | 2.02M | 1.37M | 1.08M | 787.63K | 422.32K | 390.2K | 777.07K | 719.78K |
Total Debt | 873.62K | 596.84K | 571.99K | 399.46K | 285.84K | 266.89K | 660K | 660K |
Common Stock | 79.04K | 79.04K | 205.5K | 205.5K | 205.5K | 205.5K | 150K | 100K |
Retained Earnings | -4.79M | -4.39M | -4.08M | -3.75M | -3.3M | -3M | -2.43M | -2.22M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -1.76M | -1.36M | -1.05M | -713.97K | -264.6K | 31.87K | 145.66K | -713.61K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |